Abstract
C hronic mountain sickness (CMS) is a maladaptive highaltitude disease characterized by excessive erythrocytosis (EE) and severe hypoxemia that is associated with increased cardiovascular risk. 1 Approximately 5% to 10% of high-altitude residents exhibit EE, which is a major public health problem primarily in the Andes, but also in Kyrgyzstan, Northern India, and among migrants to high altitude in Tibet and the United States. [2] [3] [4] [5] One of the highest reported prevalences is in the mining city of Cerro de Pasco, Peru, where 15% of men aged 30 to 39 years, and 34% aged 60 to 69 years exhibit EE (hemoglobin concentration [Hb] ≥21 g/dL). 6, 7 Despite its prevalence and potential for cardiovascular complications, the impact of EE on the systemic vasculature has received little attention in the literature. To date, only one group has investigated systemic endothelial function in Andeans with EE and observed impaired flow-mediated dilation (FMD) compared to Andeans without EE, [8] [9] [10] which may partially reflect the increased oxidative-nitrosative stress in EE indicated by a free radical-mediated reduction in the systemic bioavailability of nitric oxide (NO). 8, 11, 12 However, understanding of the mechanisms and extent of endothelial dysfunction in Andeans with EE is limited because the shear stress stimulus (the product of blood viscosity and shear rate) was not assessed.
Given the high hematocrit in EE, blood viscosity is likely much higher compared to non-EE Andeans. [13] [14] [15] Moderate elevations in hematocrit, and therefore blood viscosity, can be beneficial to vascular health due to increased shear stress-associated NO release. 16, 17 However, if the resistance to flow incurred by blood viscosity exceeds the shear stress-associated vasodilation, hyperviscosity impairs perfusion and can increase arterial pressure. 16, 18, 19 Additionally, in EE, NO scavenging by Hb may limit shear stress-associated NO-induced vasodilation. 16, 20, 21 Thus, documenting the interplay between Hb, viscosity, shear stress, and FMD in a population characterized by marked hyperviscosity and noted endothelial dysfunction 8, 10 may provide insight into a potential mechanism that could be directly responsible for the increased cardiovascular risk in high-altitude EE.
We sought to determine (1) endothelial function by identifying the shear stress stimulus and FMD in Andeans with and without EE, and (2) whether acute reductions in Hb and blood viscosity via isovolemic hemodilution (IVHD) improve FMD. We hypothesized that FMD would be impaired in Andeans with EE even after accounting for shear stress and FMD would improve after IVHD. Our findings indicate that hyperviscosity and high Hb contribute to reduced FMD and likely mediate the increased cardiovascular risk in Andeans with EE.
Materials and Methods
The individual data that support the findings of this study are available from the corresponding author upon reasonable request.
Ethical Approval
The Clinical Research Ethics Board of the University of British Columbia (H17-02687 and H18-01404), the Queen's University Health Sciences Research Ethics Board (number 6023174), and the Universidad Peruana Cayetano Heredia Comité de Ética (number 101686) approved all experimental procedures and protocols in adherence with the principles of the Declaration of Helsinki (except registration in a database). All participants read an in-depth study information form translated into Spanish, spoke with a Peruvian research assistant and provided written informed consent in Spanish before participating.
Participants and Experimental Protocol
Male Andean participants who were born and have been permanently living in Cerro de Pasco (4330 m above sea level) or the Pasco region who were not taking any medications and did not work in the mining industry were included in the study (detailed in Tymko et al, under review and in the online-only Data Supplement). Participants were classified as either with EE (n=19; Hb≥21 g/dL) or without EE (n=23; Hb<21 g/dL). The severity of CMS symptoms was determined using the Qinghai CMS score. 22 A score of 0 (absent) to 3 (severe) was assigned for the following signs and symptoms: breathlessness/palpitations, sleep disturbance, cyanosis, venodilation, paresthesia, headache, and tinnitus. The presence of EE (≥21 g/dL) adds 3 to the score. The sum of the score for each symptom and EE defines CMS severity as absent (0-5), mild (6-10), moderate (11) (12) (13) (14) , and severe (≥15). One participant without and 5 participants with EE were smokers and refrained from smoking the day of testing. Participants were tested a minimum of 6-hour postprandial, 12-hour postcaffeine/postalcohol, and 24-hour postexercise. 23 A venous blood sample was drawn to measure blood viscosity, Hb, and hematocrit. After lying supine for a minimum of 20 minutes, baseline blood pressure (automated blood pressure, measured in duplicate, Life Source, UA-767FAM, Canada) and oxyhemoglobin saturation from pulse oximetry (Spo 2 ; Nonin Medical, United States) were obtained. Participants rested in the supine position for 30 minutes before assessment of FMD. All participants with EE during the screening visit were invited to participate in an IVHD study and 8 volunteered. FMD was performed before and after IVHD on a separate laboratory visit (n=8). 
Doppler Ultrasound

Flow-Mediated Dilation
FMD was performed in adherence with recommended guidelines. 23, 24 One minute of baseline brachial artery diameter and blood velocity was acquired via Duplex ultrasound. Subsequently, a pneumatic cuff placed distal to the epicondyles was inflated to 250 mm Hg for 5 minutes. The cuff was then rapidly deflated, and ultrasound imaging persisted for 3-minute postdeflation. Screen capture of the ultrasound was saved as an audio-video interleave file (Camtasia Studio) for future analysis using edge-detection software. 25 
Isovolemic Hemodilution
Under local anesthesia (Lidocaine, 1.0 %) and ultrasound guidance, a 20-gauge arterial catheter (Arrow, Markham, ON, Canada) was placed in the radial or brachial artery. Following arterial catheterization, baseline measurements of FMD were performed in the contralateral arm and arterial blood gases, pH, total bioactive plasma NO (see below), oxyhemoglobin saturation (Sao 2 ), blood viscosity, Hb, hematocrit, and intraarterial pressure were recorded. Afterward, ≈20% of blood volume was removed and simultaneously replaced with an equal volume of 37°C, 5% human serum albumin (result: 1063±320 mL; 17.2±6.6% of total blood volume). The hemodilution protocol took between 60 to 120 minutes. All measures were reassessed after IVHD.
Hematologic and Biochemical Analyses
Hematologic and biochemical analyses were performed on venous blood samples in the Andeans with versus without EE comparison and arterial blood samples for the IVHD protocol (detailed in the online-only Data Supplement). Whole blood viscosity was measured in duplicate at a shear rate 225 1/s at 37°C using a cone and plate viscometer (DV2T Viscometer, Brookfield Amtek, United States) and a circulating water heating bath (TC-150, Brookfield Amtek, United States). 26, 27 Arterial blood gases, Hb, hematocrit, and Sao 2 were obtained from a calibrated blood gas analyzer (ABL-90, Radiometer, Denmark). In a subset of participants in the IVHD trial (n=6), ozonebased chemiluminescence (Sievers NOA 280i, Analytix Ltd, Durham, United Kingdom) was used to detect the combined concentration of plasma-borne nitrite (NO) and S-nitrosothiols via chemical reagent cleavage as previously described. 28 The intra-and inter-assay coefficient of variations were <10%.
Data Analysis
Observers were blinded to participant status for all analyses.
Shear Stress
Shear stress was calculated as the product of shear rate (4× peak envelope blood velocity / arterial diameter) and whole blood viscosity at a shear rate of 225 1/s. 26, 28 Antegrade, retrograde, and mean shear stress were calculated from positive, negative, and mean blood velocities, respectively. The oscillatory shear index was calculated as |retrograde shear stress| / (|antegrade shear stress|+|retrograde shear stress|). 
Flow-Mediated Dilation
Edge-detection software (FMD/BloodFlow Software Version 5.1, Reed C, Australia) 25 automatically detected peak diameter using a moving window-smoothed median across time postcuff deflation. FMD was calculated as the relative and absolute difference between peak and baseline diameter. Although shear rate is a suitable surrogate when comparing homogenous, healthy groups at sea level, 30 blood viscosity changes influence interpretation in high-altitude studies. 28, 31 The FMD stimulus was therefore quantified as the shear stress area under the curve (SS AUC60 ) 60-second postcuff deflation. 32 Peak reactive hyperemia, vascular conductance, and total reactive hyperemia were acquired as indices of resistance vessel function. [33] [34] [35] [36] [37] Blood flow was calculated as peak envelope blood velocity / 2×[π (0.5×di-ameter) 2 ], 38, 39 and vascular conductance was calculated as blood flow / mean arterial pressure. Peak reactive hyperemia was calculated as the greatest 3-second postocclusion blood flow, 28 and peak vascular conductance was calculated as peak reactive hyperemia / mean arterial pressure. 37 Total reactive hyperemia was calculated as the blood flow area under the curve 3-minute postcuff deflation. 28 
Statistical Analysis
All statistical analyses were performed using IBM SPSS 24 (International Business Machines Corp, United States). Data are presented as mean±SD. Data were assessed for normality using the Shapiro-Wilk test. When data were not normally distributed, MannWhitney rank-sum tests were performed. All normally distributed data were analyzed using a linear mixed model unless otherwise noted with a compound symmetry covariance structure with significance set at P<0.05. Participant characteristics, baseline cardiovascular variables, and FMD-associated parameters were compared between groups. The effect of IVHD on hemodynamic, blood, and FMD parameters was assessed with time (pre versus post) as a repeated factor. To account for potential effects of shear stress stimulus on FMD, analysis was additionally performed with the SS AUC60 as a covariate. 40 The slope of the Hb and blood viscosity relationship in Andeans with and without EE was compared using ANCOVA. Linear regression analyses were performed between FMD and Hb, blood viscosity, and Spo 2 .
Results
Participant Characteristics
Peak oxygen uptake and work rate did not differ between groups as reported and described in detail elsewhere (Tymko et al, under review). CMS scores were higher and Spo 2 lower in Andeans with (n=19) versus without EE (n=23) ( Table 1) . The relationship between Hb and whole blood viscosity is displayed in Figure 1A . The slope of this relationship was steeper among Andeans with compared to without EE (P=0.016). Hb and blood viscosity were 23% and 48% higher in Andeans with versus without EE (P<0.001; Figure 1B and 1C). Four participants (all with EE) had blood viscosities that exceeded the upper limit of the viscometer, thus 10.22 cP (the upper limit of the viscometer) was used as an underestimation of their blood viscosity. Including smoking status as a covariate did not impact our findings and FMD in smokers and nonsmokers were not different (smokers: 6.7±3.1%; nonsmokers: 6.8±3.0%; P=0.959).
FMD and Microvascular Function
Parameters for FMD and microvascular function are presented in Table 2 . The baseline brachial artery diameter was 14% greater in Andeans with compared to without EE (P=0.001) and related to blood viscosity (r 2 =0.311; P<0.001). Baseline shear stress parameters were not different between groups. FMD was 31% lower in Andeans with versus without EE (P=0.008; Figure 1D ). After covariate adjustment for the shear stress stimulus (SS AUC60 ; P=0.415 between groups), FMD was 28% lower in Andeans with versus without EE (P=0.013; Figure 1E) Figure 2 ).
Isovolemic Hemodilution
Parameters measured before and after IHVD are presented in Table 3 . IVHD decreased Hb by 14±5% and blood viscosity by 30±10% (both P<0.001; Figure 3A and 3B). FMD increased from 2.9±2.1% to 4.1±2.0% following hemodilution (P=0.036; Figure 3C ). There was a trend towards a lower SS AUC60 posthemodilution (P=0.076) and indices of microvascular function were not different. The improvement in FMD persisted after covariate adjustment for SS AUC60 (P=0.022; Figure 3D ). Of note, the only participant to experience a decrease in FMD posthemodilution had the lowest prehemodilution Hb. In contrast, IVHD did not alter the vascular bioavailability of (plasma) NO.
Discussion
We have provided the first comprehensive assessment of shear stress-associated endothelial function in high-altitude Andeans, a population with a high prevalence of EE. The primary findings were that (1) FMD was lower in Andeans with EE than without when accounting for the shear stress stimulus, (2) FMD was inversely related to both blood viscosity and Hb, and (3) FMD improved following IVHD-induced reductions in Hb and whole blood viscosity without changes in plasma bioactive NO. Collectively, these findings suggest that hyperviscosity and high Hb in Andeans with EE contributes to the reduced FMD by mechanisms that appear to be independent of basal plasma bioactive NO. This reduced functional response to increased shear stress may be considered an important vascular property that predisposes Andeans with EE to increased cardiovascular risk. The findings of the present investigation are consistent with previous observations of impaired FMD in Andeans with CMS compared to those without. [8] [9] [10] Importantly, these findings confirm the evidence of reduced FMD by measuring and adjusting for the shear stress stimulus for FMD. [40] [41] [42] The magnitude of FMD in this population was inversely related to whole blood viscosity and Hb, suggesting that the EE-associated hyperviscosity and high Hb contributes, at least in part, to the impaired endothelial function. Hemodilution in polycythemic patients has previously been shown to improve FMD 43 and is a common, although incompletely understood, treatment option in CMS [44] [45] [46] [47] [48] [49] that may help to liberate bioavailable NO by reducing Hb-mediated scavenging. 16, 20, 21 In the present investigation, IVHD improved FMD and decreased blood viscosity and Hb, without changing Sao 2 or basal plasma bioactive NO. The finding of no net effect of IVHD on plasma bioactive NO, the reactant of oxidativenitrosative stress, 8, 50 suggests that acute improvements in FMD following IVHD were not dependent on changes in oxidativenitrosative stress (as indexed via plasma NO). This finding provides experimental evidence that the reduced FMD is acutely mediated, in part, by high levels of blood viscosity and Hb scavenging of shear stress-mediated NO production. Rimoldi et al 10 did not observe changes in FMD following hemodilution in 9 participants with CMS; however, our hemodilution protocol differed in 2 ways. First, we replaced blood with human serum albumin as opposed to saline to ensure the fluid remained in the intravascular space. Second, we observed a 3-fold greater reduction in Hb (22.1±1.7 g/dL to 19.1±1.7 g/dL versus 21.4±1.0 g/dL to 20.4±1.3 g/dL). Thus, the magnitude of hemodilution in the study by Rimoldi et al 10 may not have been sufficient to improve FMD. By contrast, Rimoldi et al 10 demonstrated that oxygen supplementation improved FMD in hypoxemic participants, perhaps because oxygenated red blood cells scavenge NO at a slower rate than deoxygenated red blood cells. 20 In line with this observation, we noted a relationship between Spo 2 and FMD (r Blood viscosity elicits opposing resistive and shear stressassociated vasodilatory effects on hemodynamics. 51, 52 Modest increases in blood viscosity have been shown to reduce blood pressure via increased shear stress-associated NO formation but increasing viscosity >50% increased blood pressure. 52 Moderate polycythemia may be associated with greater FMD in hypoxemic patients. 53 However, the relationship between blood viscosity and Hb becomes steeper in Andeans with EE ( Figure 1 ). Although the mechanisms that determine this relationship remain to be established (see below), endothelial dysfunction in instances of high levels of blood viscosity and Hb may render individuals especially susceptible to increased cardiovascular risk as both whole blood viscosity 54, 55 and reduced FMD 56, 57 predict cardiovascular risk and events. Enlarged brachial artery diameters have previously been reported in participants with EE, 10 which appears to be a phenotypic characteristic of this maladaptive response to chronic hypoxemia. The large diameter may be the result of structural adaptations in response to high blood viscosity-associated shear stress, the so-called shear stress normalization hypothesis. 58, 59 Additionally, there may be a role for chronic hypoxemia in maintaining the conduit artery in a vasodilated state, supported by the observation that oxygen supplementation decreases brachial artery diameter in patients with CMS. 10 Thus, enlarged conduit artery diameter is a fundamental component of EE pathophysiology. In non-EE populations, an inverse relationship between baseline diameter and FMD has been observed. 60 This has been interpreted to suggest that the same endothelial function is reflected by a progressively smaller percent and absolute FMD response as baseline artery dimensions increase. 60 However, FMD increased with hemodilution while baseline artery diameter did not change, providing support that the larger baseline diameters per se do not explain the impaired FMD in EE.
We have identified a role for high Hb and blood viscosity in contributing to the reduced FMD in Andeans with EE. However, the mechanisms responsible for the low FMD in Andeans with EE are likely multifaceted and cannot be completely elucidated from the present study. For instance, increased systemic free radical formation has been reported in Andeans with EE compared to Andeans without, 8, 12 and this likely contributes to the lower FMD by chronically inactivating NO (oxidativenitrosative stress). 8, 50 Additionally, cell-free Hb is a 1000-fold more potent NO scavenger [61] [62] [63] [64] than red blood cell Hb and can impair endothelium-dependent vasodilation. 61, 65 Polycythemic patients at sea level have elevated levels of cell-free Hb compared to healthy control participants, and polycythemic patients with hypertension have higher cell-free Hb compared to normotensive polycythemic patients. 66 Thus, cell-free Hb may play a role in the NO scavenging and subsequent reduced FMD and increased cardiovascular risk in Andeans with EE. 1 Further, measures of erythropoietin to soluble erythropoietin receptor (an erythropoietin antagonist) ratio may have provided additional mechanistic insight, as this ratio is increased in CMS 67, 68 and erythropoietin has been shown to impair endothelial function in humans. 69 Therefore, future investigations should investigate markers of oxidative stress, NO bioavailability (in both plasma and red blood cell), cell-free Hb, and levels of erythropoietin to better dissect the mechanisms linking EE with reduced FMD and related adverse vascular outcomes.
Perspectives
Andean highlanders with EE had reduced FMD compared to those without EE, and blood viscosity and Hb correlated with FMD in this population. IVHD reduced Hb and blood viscosity and improved FMD. These findings identify an Hb/hyperviscosity-associated reduction in FMD as a potential mechanistic link between EE and increased cardiovascular risk. Data are presented as mean±SD. BMI indicates body mass index; CMS, chronic mountain sickness; FMD, flow-mediated dilation; NO, nitric oxide; Pao 2 , arterial partial pressure of oxygen; Paco 2 , arterial partial pressure of carbon dioxide; Sao 2 , arterial oxyhemoglobin saturation; SS AUC60 , shear stress area under the curve 60-second postcuff deflation. Total bioactive NO refers to the combined concentration of (plasma) nitrite and S-nitrosothiols. *P<0.05 vs pre.
